Glenda Domingos Mascarenhas
Research Subjects
Research Interests
Glenda Domingos Mascarenhas has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Andressa da Silva Cazote
Laboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil
1 shared publication - Beatriz Grinsztejn
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil
1 shared publication - Carmem Beatriz Wagner Giacoia-Gripp
Laboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil
1 shared publication - Cynthia Machado Cascabulho
Flow Cytometry Platform—Multiparametric Analysis Unit, Oswaldo Cruz Institute, Rio de Janeiro 21040-360, Brazil
1 shared publication - Dalziza Victalina de Almeida
Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil
1 shared publication - Diogo Gama Caetano
Laboratório de AIDS & Imunologia Molecular, Instituto Oswaldo Cruz (IOC), FIOCRUZ, Rio de Janeiro 21040-360, Brazil
1 shared publication
Latest Publications
- Open Access
Functional Profile of γδ T Cells in Severe and Moderate COVID-19: A Brazilian Cross-Sectional Study
This study aimed to identify the distinct intrinsic response potential of γδ T cells from COVID-19 patients with different illness severities, to better understand the implication of these cells in COVID-19 disease. Forty-four COVID patients were enrolled at hospitalization and classified as: moderate without oxygen support (MWO2; N = 15), moderate with oxygen support (MO2; N = 15), or severe disease requiring mechanical ventilation (SD; N = 14). γδ T cells were characterized ex vivo, isolated from peripheral blood cells, stimulated in vitro with OKT3 and K562 cells, and evaluated for functional markers by flow cytometry. Ex vivo analysis identified 16.21% of total γδ T cells as Vδ1−Vδ2−. SD patients presented a lower frequency of TRAIL+ and of IL-17-producing Vδ2 cells, as well as lower value of fluorescence intensity values for TNF-α in Vδ2 cells, than MWO2 patients (p < 0.05). In addition, paired analyses showed a lower frequency of IL-17-producing than CD161+ Vδ2 cells in SD patients (p < 0.05). These observations suggest a more restricted response potential of the Vδ2 subset in severe disease, show the impact of general immune dysregulation on these cells, or even suggest some role for IL-17-producing Vδ2 cells in preventing critical symptoms.
Open AccessFunctional Profile of γδ T Cells in Severe and Moderate COVID-19: A Brazilian Cross-Sectional Study
This study aimed to identify the distinct intrinsic response potential of γδ T cells from COVID-19 patients with different illness severities, to better understand the implication of these cells in COVID-19 disease. Forty-four COVID patients were enrolled at hospitalization and classified as: moderate without oxygen support (MWO2; N = 15), moderate with oxygen support (MO2; N = 15), or severe disease requiring mechanical ventilation (SD; N = 14). γδ T cells were characterized ex vivo, isolated from peripheral blood cells, stimulated in vitro with OKT3 and K562 cells, and evaluated for functional markers by flow cytometry. Ex vivo analysis identified 16.21% of total γδ T cells as Vδ1−Vδ2−. SD patients presented a lower frequency of TRAIL+ and of IL-17-producing Vδ2 cells, as well as lower value of fluorescence intensity values for TNF-α in Vδ2 cells, than MWO2 patients (p < 0.05). In addition, paired analyses showed a lower frequency of IL-17-producing than CD161+ Vδ2 cells in SD patients (p < 0.05). These observations suggest a more restricted response potential of the Vδ2 subset in severe disease, show the impact of general immune dysregulation on these cells, or even suggest some role for IL-17-producing Vδ2 cells in preventing critical symptoms.